1h Free Analyst Time
Global Connected Medical Devices Market 2021-2025Speak directly to the analyst to clarify any post sales queries you may have.
The publisher has been monitoring the connected medical devices market and it is poised to grow by $ 81.26 bn during 2021-2025 progressing at a CAGR of 29% during the forecast period. The report on the connected medical devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of chronic diseases, increasing demand for connected wearable medical devices and remote patient monitoring systems, and increasing geriatric population. In addition, the rising prevalence of chronic diseases is anticipated to boost the growth of the market as well.
The connected medical devices market analysis includes product segments and geographical landscapes.
The connected medical devices market is segmented as below:
By Product
- Capital-intensive
- Physiological monitors
- Wearable medical
By Geographical Landscapes
- North America
- Europe
- Asia
- ROW
This study identifies the technological advancements as one of the prime reasons driving the connected medical devices market growth during the next few years. Also, the increasing online presence of vendors and increasing adoption of connected medical devices at homecare setting will lead to sizable demand in the market.
The report on connected medical devices market covers the following areas:
- Connected medical devices market sizing
- Connected medical devices market forecast
- Connected medical devices market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading connected medical devices market vendors that include Abbott Laboratories, Alphabet Inc., Boston Scientific Corp., Dexcom Inc., F. Hoffmann-La Roche Ltd., General Electric Co., Koninklijke Philips NV, LifeScan IP Holdings LLC, Medtronic Plc, and OMRON Corp.. Also, the connected medical devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Table of Contents
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Product
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
Exhibit
Executive Summary
The publisher recognizes the following companies as the key players in the connected medical devices market: Abbott Laboratories, Alphabet Inc., Boston Scientific Corp., Dexcom Inc., F. Hoffmann-La Roche Ltd., General Electric Co., Koninklijke Philips NV, LifeScan IP Holdings LLC, Medtronic Plc, and OMRON Corp.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is technological advancements.'
According to the report, one of the major drivers for this market is the rising prevalence of chronic diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Alphabet Inc.
- Boston Scientific Corp.
- Dexcom Inc.
- F. Hoffmann-La Roche Ltd.
- General Electric Co.
- Koninklijke Philips NV
- LifeScan IP Holdings LLC
- Medtronic Plc
- OMRON Corp.